Eric J. Topol - Concepedia

Author

Eric J. Topol

Also Known As

Alexandra J. Lansky, Califf, Robert, Datta, Suvrankar, E J TOPOL, E J Topol, E TOPOL, E Topol, E. J Topol, E. J. TOPOL, E. J. Topol

1.7K

Publications

177.8K

Citations

202

H-Index

496

Concepts

All Affiliations

Cleveland Clinic Scripps Research Institute University of Michigan Duke Medical Center Cleveland Foundation

About

Eric J. Topol is an author at Cleveland Clinic specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	21	36	3.6K
2	Health Sciences	20	26	2.8K
3	Business	3	3	65
4	Education	2	2	99
5	Arts	1	1	119

Eric J. Topol

843

Publications

113.8K

Citations

170

H-Index

Page 1

	Year	Citations
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention Steven R. Steinhubl, Peter B. Berger, J. Tift Mann, JAMA	2002	3.1K
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Deepak L. Bhatt, Keith A.A. Fox, Werner Hacke, New England Journal of Medicine	2006	2.8K
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Sam Ellis, Michel Vandormael, Michael J. Cowley, Circulation Clinical DeterminantsHeart FailureMultivessel Coronary DiseaseEndovascular TechniquePatient Selection	1990	1.3K
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Arman T. Askari, Samuel Unzek, Zoran Popović, The Lancet Regenerative MedicineCardiomyopathyEngineeringStem-cell HomingMedicine	2003	1.3K
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention A. Michael Lincoff, John A. Bittl, Robert A. Harrington, JAMA	2003	1.2K
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure Steven E. Nissen, E. Murat Tuzcu, Peter Libby, JAMA	2004	1.1K
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia E. Magnus Ohman, Paul W. Armstrong, Robert H. Christenson, New England Journal of Medicine	1996	1.1K
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Eric J. Topol The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseCoronary Artery DiseasePlatelet Glycoprotein-iib/iiia Blockade	1998	1.1K
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Kerry L. Lee, Lynn H. Woodlief, Eric J. Topol, Circulation	1995	1.1K
Prognostic Value of Myeloperoxidase in Patients with Chest Pain Marie‐Luise Brennan, Marc S. Penn, Frederick Van Lente, New England Journal of Medicine	2003	1.1K

Page 1